Use of slow-release oral morphine for the treatment of opioid dependence

European Addiction Research

Volumn 11, Issue 3, 2005, Pages 145-151

  Kraigher, Dominik ^a   Jagsch, Reinhold ^b   Gombas, Wolfgang ^a   Ortner, Romana ^a   Eder, Harald ^a   Primorac, Andjela ^a   Fischer, Gabriele ^a,c  

^a University Clinic of Neurology   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Maintenance therapy; Opioid dependence; Oral slow release morphine

Indexed keywords

BENZODIAZEPINE DERIVATIVE; COCAINE; DIAMORPHINE; MORPHINE; OPIATE;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; OUTCOMES RESEARCH; PRIORITY JOURNAL; SATISFACTION; SLOW RELEASE FORMULATION; SUBSTANCE ABUSE; URINALYSIS; WITHDRAWAL SYNDROME;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MORPHINE; NARCOTICS; OPIOID-RELATED DISORDERS;

EID: 21344455084     PISSN: 10226877     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085550     Document Type: Article

References (39)

1. O'Brien CP: Overview: The treatment of drug dependence. Addiction 1994;89:1565-1569.
2. Verthein U, Degkwitz P, Krausz M: Mental disorders and the course of opiate dependence (in German). Psychiatr Prax 2000;27:77-85.
3. Dole VP, Nyswander M: A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride. J Am Med Assoc 1965;193:646-650.
4. Ling W, Rawson RA, Compton MA: Substitution pharmacotherapies for opioid addiction: From methadone to LAAM and buprenorphine. J Psychoactive Drugs 1994;26:119-128.
5. Novick DM, Richman BL, Friedman JM, Friedman JE, Fried C, Wilson JP, Townley A, Kreek MJ: The medical status of methadone maintenance patients in treatment for 11-18 years. Drug Alcohol Depend 1999;33:235-245.
6. Kolar AF, Brown BS, Weddington WW, Ball JC: A treatment crisis: Cocaine use by clients in methadone maintenance programs. J Subst Abuse Treat 1990;7:101-107.
7. Pfersmann D, Presslich O, Pakesch G, Hollerer E, Pfersmann V: Organisation and implementation of the Austrian methadone programme and initial results (in German). Nervenarzt 1990;61:438-443.
8. Schwaighofer K: The New Craze Centre Right: Supplement, Regulations and Decrees (in German). Vienna, WUV-Universitäts Verlag, 1998.
9. Fischer G, Gombas W, Eder H, Jagsch R, Peternell A, Stühlinger G, Pezawas L, Aschauer HN, Kasper S: Buprenorphine versus methadone maintenance for the treatment of opioid dependence. Addiction 1999;94:1337-1347.
10. Clark N: High-dose buprenorphine may be an effective interim treatment for long-term heroin users waiting for drug-assisted rehabilitation. Evid Based Ment Health 2003;6:30.
11. Derks JTM: The efficacy of the Amsterdam morphine-dispensing programme; in Ghodse HA, Kaplan CD, Mann RDS (eds): Drug Misuse and Dependence. Park Ridge/NY, Parthenon, 1990, pp 85-108.
12. Sherman JP: Managing heroin addiction with a long-acting morphine product (Kapanol). Med J Aust 1996;165:239.
13. Fischer G, Presslich O, Diamant K, Schneider C, Pezawas L, Kasper S: Oral morphine-sulphate in the treatment of opiate-dependent patients. Alcoholism 1996;32:35-43.
14. Fischer G, Jagsch R, Eder H, Gombas W, Etzersdorfer P, Schmidl-Mohl K, Schatten C, Weninger M, Aschauer HN: Comparison of methadone and slow-release morphine maintenance in pregnant addicts. Addiction 1999;94:231-239.
15. Kraigher D, Ortner R, Eder H, Schindler S, Fischer G: Slow-release morphine hydrochloride for maintenance therapy of methadone dependence (in German). Wien Klin Wochenschr 2002;114:904-910.
16. Mitchell TB, White JM, Somogyi AA, Bochner F: Slow-release oral morphine versus methadone: A crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence. Addiction 2004;99:940-945.
17. American Psychiatric Association (APA): Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, APA, 1994.
18. Syva Co: Emit® Assay Troubleshooting Guide. Palo Alto, Syva Co, 1993.
19. Scheurich A, Müller MJ, Wetzel H, Anghelescu I, Klawe C, Ruppe A, Lorch B, Himmerich H, Heidenreich M, Schmid G, Hautzinger M, Szegedi A: Reliability and validity of the German version of the European Addiction Severity Index (EuropASI). J Stud Alcohol 2000;61:916-919.
20. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
21. Fagerström KO: Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 1978;3:235-241.
22. Wang RIH, Wiesen RL, Lamid S, Roh BL: Rating the presence and severity of opiate dependence. Clin Pharmacol Ther 1974;16:653-658.
23. Von Zerssen D: Clinical Self-Rating Scales of the Munich Psychiatric Information System (PSYCHIS München); in Sartorius N, Bau TA (eds): Assessment of Depression. Berlin, Springer, 1986, pp 270-303.
24. NCSS: NCSS Statistical Software. Kayasville/UT, NCSS, 2000.
25. Cytel: StatXact® 4.0.1. Cambridge/MA, Cytel Software Corp, 2002.
26. Niveau G, Rougemont AL, La Harpe R: Meth-adone maintenance treatment, criminality and overdose-related deaths. An ecological study, 1983-1999. Eur J Public Health 2002;12:224-227.
27. Mattick RP, Kinber J, Breen C, Davoli M: Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database System Reviews CD002207, 2003.
28. Uehlinger C, Deglon J, Livoti S, Petitjean S, Waldvogel D, Ladewig S: Comparison of buprenorphine and methadone in the treatment of opioid dependence. Swiss multicentre study. Eur Addict Res 1998;4(suppl 1):13-18.
29. Yacoubian GS Jr, Urbach BJ: To pee or not to pee: Reconsidering the need for urinalysis. J Drug Educ 2002;32:261-270.
30. Franke P, Neef D, Weiffenbach O, Gansicke M, Hautzinger M, Maier W: Psychiatrische Komorbidität in Risikogruppen für Abhängigkeit: Psychiatric comorbidity in risk groups of opioid addiction: A comparison between opioid dependent and non-opioid dependent prisoners [in jail due to the German narcotics law] (in German). Fortschr Neurol Psychiatr 2003;71:37-44.
31. Ortner R, Peternell A, Kraigher D, Schindler SD, Topitz A, Fischer G: Cocaine abuse in maintenance therapy with methadone in narcotic-dependent patients (in German). Wien Klin Wochenschr 2001;113:934-938.
32. 450 2D6 modifies codeine abuse liability. J Clin Psychopharmacol 2000;20:435-444.
33. Pond SM, Kreek MJ, Tong TV, Raghunat J, Benowitz NL: Altered methadone pharmacokinetics in methadone-maintained pregnant women. J Pharmacol Exp Ther 1985;233:1-6.
34. 450 3A4. Toxicology 1997;117:13-23.
35. Van den Brink W, Hendriks VM, Blanken P, Koeter MWJ, van Zwieten BJ, van Ree JM: Medical prescription of heroin to treatment resistant heroin addicts: Two randomised controlled trials. Br Med J 2003;327:310.
36. Merrill BO: Policy progress for physician treatment of opiate addiction. J Gen Intern Med 2002;17:361-368.
37. Gossop M, Marsden J, Stewart D, Lehmann P, Strang J: Methadone treatment practices and outcome for opiate addicts treated in drug clinical and in general practice: Results from Nation Treatment Outcome Research Study. Br J Gen Pract 1999;49:31-34.
38. Lintzeris N, Ritter A, Dunlop A, Muhleisen P: Training primary health care professionals to provide buprenorphine and LAAM treatment. Subst Abus 2002;23:245-254.
39. Thirion X, Lapierre V, Micallef J, Ronfle E, Masut A, Pradel V, Co C, Mabriez JC, Sanmarco JL: Buprenorphine prescription by general practitioners in a French region. Drug Alcohol Depend 2002;65:197-204.